These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 4317534)

  • 21. Analogues of 4-(3,4-dimethoxybenzyl)-2-imidazolidinone as potent inhibitors of rat erythrocyte adenosine cyclic 3',5'-phosphate phosphodiesterase.
    Sheppard H; Wiggan G
    Mol Pharmacol; 1971 Jan; 7(1):111-5. PubMed ID: 5552247
    [No Abstract]   [Full Text] [Related]  

  • 22. Role of cyclic AMP in human adipose tissue lipolysis.
    Burns TW; Terry BE; Langley PE; Robison GA
    Adv Cyclic Nucleotide Res; 1980; 12():329-41. PubMed ID: 6250365
    [No Abstract]   [Full Text] [Related]  

  • 23. Effects of growth hormone on the lipolytic response of adipose tissue to theophylline.
    Goodman HM
    Endocrinology; 1968 May; 82(5):1027-34. PubMed ID: 4172452
    [No Abstract]   [Full Text] [Related]  

  • 24. Metabolic and circulatory effects of theophylline in canine subcutaneous adipose tissue.
    Fredholm BB
    Acta Pharmacol Toxicol (Copenh); 1970; 28(1):46. PubMed ID: 4325959
    [No Abstract]   [Full Text] [Related]  

  • 25. Effects of theophylline and catecholamines on lipolysis and glycogenolysis in vivo.
    Triner L; Nahas GG
    J Pharmacol Exp Ther; 1966 Sep; 153(3):569-72. PubMed ID: 5921531
    [No Abstract]   [Full Text] [Related]  

  • 26. The role of cyclic AMP in the actions of some lipolytic and anti-lipolytic agents.
    Butcher RW
    Horm Metab Res; 1970; 2():Suppl 2:5-10. PubMed ID: 4403191
    [No Abstract]   [Full Text] [Related]  

  • 27. Vascular and metabolic effects of theophylline, dibuturyl cyclic AMP and dibuturyl cyclic GMP in canine subcutaneous adipose tissue in situ.
    Fredholm BB
    Acta Physiol Scand; 1974 Jan; 90(1):226-36. PubMed ID: 4360701
    [No Abstract]   [Full Text] [Related]  

  • 28. Certain characteristic features of the lipolytic factor from rat submaxillary salivary glands.
    Zimowska U
    Acta Physiol Pol; 1983; 34(5-6):555-62. PubMed ID: 6388245
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of histamine and its derivatives on lipolysis in isolated rat fat cells.
    Nakano J; Oliver RD
    Arch Int Pharmacodyn Ther; 1970 Aug; 186(2):339-44. PubMed ID: 4331695
    [No Abstract]   [Full Text] [Related]  

  • 30. Effect of antilipolytic compounds on cyclic 3',5'-adenosine monophosphate activation of adipose tissue lipolysis.
    Schreibman PH; Wilson DE; Arky RA
    Diabetes; 1971 Mar; 20(3):146-50. PubMed ID: 4323534
    [No Abstract]   [Full Text] [Related]  

  • 31. Effects of ouabain and K+-free medium on activated lipolysis and epinephrine-stimulated glycogenolysis.
    Kypson J; Triner L; Nahas GG
    J Pharmacol Exp Ther; 1968 Jan; 159(1):8-17. PubMed ID: 5643953
    [No Abstract]   [Full Text] [Related]  

  • 32. Catecholamines and metabolism of human adipose tissue. V. Studies on the incorporation of glucose-1-14C into lipids and the re-esterification of FFA by human omental tissue in vitro.
    Efendić S; Ostman J
    Acta Med Scand; 1970 Jun; 187(6):493-502. PubMed ID: 4318745
    [No Abstract]   [Full Text] [Related]  

  • 33. Effects of norepinephrine, theophylline and dibutyryl cyclic AMP on in vitro lipolysis of human adipose tissue in obesity.
    Gries FA; Berger M; Neumann M; Preiss H; Liebermeister H; Hesse-Wortmann C; Jahnke K
    Diabetologia; 1972 Apr; 8(2):75-83. PubMed ID: 4337960
    [No Abstract]   [Full Text] [Related]  

  • 34. [The effect of nicotinic acid and propranolol on the lipolytic action of catecholamines and peptide hormones in vitro].
    Schwandt P; Hartmann T; Karl HJ
    Z Gesamte Exp Med Einschl Exp Chir; 1967; 143(1):79-84. PubMed ID: 4297519
    [No Abstract]   [Full Text] [Related]  

  • 35. On the role of adenyl cyclase in the regulation of lipolysis in fasting.
    Brodie BB; Krishna G; Hynie S
    Biochem Pharmacol; 1969 May; 18(5):1129-34. PubMed ID: 5789779
    [No Abstract]   [Full Text] [Related]  

  • 36. Inhibition of cyclic AMP formation and lipolysis in rat adipose tissue by nicotinic acid.
    Andersson R; Harthon L; Hedström M; Lundholm L
    Atherosclerosis; 1973; 18(3):399-406. PubMed ID: 4356384
    [No Abstract]   [Full Text] [Related]  

  • 37. [Effect of nicotinic acid and beta-adrenergic blockade on lipid mobilization during prolonged irradiation of rats].
    Ahlersová E; Ahlers I; Sedláková A; Malatová Z; Praslicka M
    Radiobiologiia; 1973; 13(1):113-6. PubMed ID: 4719870
    [No Abstract]   [Full Text] [Related]  

  • 38. Valinomycin as an antilipolytic agent. Effects on cyclic 3',5'-adenylic acid, adenyl cyclase, respiration, and glucose metabolism in borwn and white fat cells.
    Fain JN; Loken SC
    Mol Pharmacol; 1971 Jul; 7(4):455-64. PubMed ID: 4329683
    [No Abstract]   [Full Text] [Related]  

  • 39. The effect of noradrenaline on the intermediate metabolism of brown adipose tissue.
    Beviz A; Mohme-Lundholm E
    Acta Pharmacol Toxicol (Copenh); 1967; 25():Suppl 4:21-2. PubMed ID: 5630929
    [No Abstract]   [Full Text] [Related]  

  • 40. Free fatty acids as feedback regulators of adenylate cyclase and cyclic 3':5'-AMP accumulation in rat fat cells.
    Fain JN; Shepherd RE
    J Biol Chem; 1975 Aug; 250(16):6586-92. PubMed ID: 169252
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.